How Europe Buys Generic Drugs - and Why Itâs Not What You Think
Every year, European governments spend over âŹ2 trillion on public contracts. Roughly one in seven euros of that goes to healthcare - and most of it buys generic drugs. But hereâs the twist: itâs not the lowest bidder who always wins. In fact, the cheapest option often loses. Thatâs because Europe doesnât just buy drugs - it buys value.
Generic medicines are the backbone of affordable healthcare across the EU. Theyâre chemically identical to branded drugs but cost 80% less. Yet getting them into hospitals and pharmacies isnât as simple as picking the lowest price. Instead, governments use a complex, tightly regulated system called tendering. Itâs designed to be fair, transparent, and smart. And if youâre a manufacturer trying to sell generics in Europe, understanding how it works isnât optional - itâs survival.
The Rules of the Game: What Makes Europeâs System Different
Unlike many countries where drug purchases are handled quietly behind closed doors, Europeâs system is built on openness. Since 1977, EU law has required all public tenders above certain value thresholds to be published in the Official Journal of the European Union. Today, thatâs done through Tenders Electronic Daily (TED), the central platform where every public contract notice is posted. Anyone, anywhere in the EU, can see whatâs being bought, whoâs bidding, and how the winner was chosen.
The core principles are simple: no discrimination, no hidden rules, and everything must be proportional. That means a small Belgian pharmacy canât be forced to prove it has âŹ10 million in annual revenue just to bid on a âŹ500,000 drug order. The requirement must match the scale of the contract. This rule alone shuts out many large, non-EU firms that canât meet arbitrary financial thresholds - and levels the playing field for smaller European manufacturers.
But the real game-changer? The evaluation method. Most countries pick the lowest price. Europe doesnât. It uses something called MEAT - Most Economically Advantageous Tender. That means price is just one factor. Quality, reliability, delivery speed, sustainability, and even innovation matter too. In 2022, the EU updated its rules to require that at least 50% of the scoring in any tender over âŹ1 million must go to non-price factors. Thatâs not a suggestion - itâs the law.
How the Bidding Process Actually Works
There are five main ways European buyers run their generic drug tenders. Each has its own pros and cons - and knowing which one youâre up against changes your strategy.
- Open Procedure: Any supplier can submit a bid. Itâs the most transparent, but also the most time-consuming. About 45% of EU tenders use this. Good for big players with lots of resources.
- Restricted Procedure: Suppliers first apply to be pre-qualified. Only those who pass get to submit a full bid. This cuts down the number of bids from hundreds to maybe 10-20. About 35% of tenders use this. Itâs faster, but harder for new entrants to break in.
- Competitive Dialogue: Used for complex purchases where the buyer doesnât yet know exactly what they need. Suppliers talk with the buyer, suggest improvements, and then bid. Common in high-tech medical devices - less so for generics, but growing.
- Framework Agreements: The buyer picks a shortlist of suppliers (often 3-5) who can supply over a set period, say 3-5 years. Then, when a hospital needs drugs, it runs a mini-bid among those pre-approved suppliers. This is huge in generics. Think of it like a wholesale club where youâre already on the membership list.
- Dynamic Purchasing Systems: An electronic system where suppliers can join at any time. New bidders can enter even after the system is live. Great for fast-changing markets like generics.
Most generic drug contracts in Europe are won through framework agreements. Why? Because hospitals donât want to re-bid every six months. They want predictability. So if you can get on the list, youâve got a steady stream of orders - even if each one is small.
Winning Isnât Just About Price - Hereâs What Really Matters
Letâs say youâre a generic drug maker from Poland trying to win a tender in Germany. Your price is 10% lower than the next bidder. That should win, right? Not always.
Hereâs what actually gets scored:
- Price (max 50%): Still important, but only half the story.
- Quality and Compliance (15-20%): Do you have GMP certification? Has your facility passed EU inspections? Are your batch records clean?
- Delivery Reliability (10-15%): Can you deliver on time, every time? Late shipments mean hospital stockouts - and thatâs a big no-no.
- Sustainability (5-10%): Is your packaging recyclable? Do you use renewable energy in production? Are you reducing carbon emissions? In 2023, 68% of high-value tenders included sustainability criteria.
- Technical Support (5-10%): Do you offer training for pharmacists? Do you provide clear labeling in local languages? Do you have a local contact for urgent issues?
One Finnish supplier won a âŹ3 million tender in 2022 not because they were cheapest - they were third. But they offered a digital dashboard that showed real-time inventory levels to hospitals. That cut waste by 18%. Thatâs innovation. Thatâs value.
The Hidden Costs - And Why Small Companies Struggle
Getting into the system isnât cheap. A 2023 survey by Eurochambres found small businesses spend an average of 117 hours per tender. Thatâs nearly three full work weeks. For a company with five employees, thatâs time taken away from production.
Then thereâs the paperwork. You need:
- European Single Procurement Document (ESPD) - a standardized form now used across 27 countries.
- Proof of financial standing.
- Quality certificates (GMP, ISO).
- Environmental impact reports.
- Local language translations for all documentation.
And if you misclassify your product using the wrong CPV code? Your bid gets rejected. In 2022, 23% of rejected bids were due to this error.
Even when you win, itâs not guaranteed income. A French SME won a âŹ200,000 framework agreement in 2022. They spent six months preparing. Then, over the next 18 months, they got just two mini-tenders - worth âŹ12,000 total. The cost of qualifying? âŹ45,000. Thatâs a loss.
Thatâs why many small manufacturers now team up. Two or three companies share the bidding cost, pool their documentation, and bid as a consortium. Itâs becoming common - and smart.
Whatâs Changing - And Whatâs Coming
Europeâs tendering system is evolving fast. Hereâs whatâs new:
- AI is helping evaluate bids: Pilot programs in France and Finland use AI to check compliance and scoring consistency. Results? 30% faster decisions with 99.2% accuracy.
- Electronic bidding is now the norm: 76% of tenders are fully digital in 2023 - up from 39% in 2016. By 2027, itâll be 95%.
- Sustainability is mandatory: By 2025, 85% of high-value tenders will include environmental criteria. By 2028, circular economy rules (like reusable packaging) will be expected in 75% of cases.
- More focus on SMEs: The EU is pushing for at least 20% of tender value to go to small businesses by 2030. New tools are being rolled out to simplify bidding for them.
The biggest shift? The move from buying drugs to buying health outcomes. Buyers arenât just looking for pills - theyâre looking for systems that reduce waste, prevent shortages, and support digital health integration. The companies that adapt will thrive. The ones that donât will be left behind.
What You Need to Do Now
If youâre a generic drug supplier aiming for Europe:
- Register on TED and set up email alerts for your product codes.
- Get your ESPD ready - itâs your passport to every tender.
- Donât just compete on price. Build a value story: reliability, sustainability, support.
- Target framework agreements - theyâre the real goldmine.
- Join forces with other small suppliers if you canât handle the cost alone.
- Learn the CPV codes. Get them wrong, and youâre out before you start.
Europeâs system isnât easy. But itâs fair. It rewards those who plan ahead, document well, and understand that value isnât just a number on a spreadsheet. Itâs trust. Itâs consistency. Itâs knowing that when a hospital runs out of a drug, youâre the one who shows up - on time, every time.
What is MEAT in European tendering?
MEAT stands for Most Economically Advantageous Tender. Itâs the evaluation method used in EU public procurement where the winning bid isnât necessarily the cheapest. Instead, itâs chosen based on a mix of price and non-price factors like quality, delivery reliability, sustainability, and technical support. By law, at least 50% of the scoring in tenders over âŹ1 million must go to these non-price criteria.
Can non-EU companies bid on European generic drug tenders?
Yes, but only if theyâre based in countries that have trade agreements with the EU - like Norway, Iceland, or Switzerland. Companies from outside these regions canât bid unless they have a legal entity established within the EU. Even then, they must meet all local regulatory and documentation requirements, including GMP certification and language translations.
Why are framework agreements so common in generic drug procurement?
Framework agreements allow hospitals and health authorities to pre-select a group of approved suppliers for a set period - usually 3 to 5 years. Instead of running a full tender every time they need drugs, they run a quick mini-bid among the pre-approved suppliers. This saves time, reduces administrative costs, and ensures consistent supply. For suppliers, it means steady, predictable revenue - even if each order is small.
How do sustainability criteria affect generic drug tenders?
Sustainability is now a major scoring factor. Buyers look at packaging materials (can it be recycled?), production energy use (is it from renewable sources?), and logistics (are shipments optimized to reduce emissions?). In 2023, 68% of high-value tenders included these criteria. By 2025, that number is expected to rise to 85%. Companies using eco-friendly packaging or carbon-neutral logistics gain a clear advantage.
Whatâs the biggest mistake suppliers make when bidding?
The most common mistake is misclassifying the product using the wrong CPV (Common Procurement Vocabulary) code. This leads to automatic rejection. Other big errors include underestimating documentation requirements, ignoring non-price evaluation criteria, and failing to translate materials into the local language. Many also donât realize that the tender isnât just about price - they need to prove reliability, compliance, and support.
Is electronic tendering mandatory in Europe?
Yes, for all tenders above âŹ134,000. Since 2022, electronic submission has been required across the EU. By 2027, the goal is 95% of all public tenders to be fully digital. Paper submissions are no longer accepted in most member states. Suppliers must use certified e-procurement platforms and have digital signatures ready.
Jhoantan Moreira
February 3, 2026 AT 04:49Meenal Khurana
February 3, 2026 AT 06:03caroline hernandez
February 3, 2026 AT 16:02Amit Jain
February 4, 2026 AT 17:44Justin Fauth
February 6, 2026 AT 10:42Joseph Cooksey
February 7, 2026 AT 02:03Sherman Lee
February 7, 2026 AT 21:17Kunal Kaushik
February 7, 2026 AT 22:35Joy Johnston
February 8, 2026 AT 21:05Keith Harris
February 10, 2026 AT 11:17